Patents by Inventor Arnaud BOURIN

Arnaud BOURIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridine derivatives as soft rock inhibitors
    Patent number: 9850234
    Abstract: The present invention relates to new kinase inhibitors, more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including Respiratory and Gastro-Intestinal diseases.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: December 26, 2017
    Assignee: Redx Pharma PLC
    Inventors: Sandro Boland, Arnaud Bourin, Olivier Defert, Dirk Leysen
  • PYRIDINE DERIVATIVES AS SOFT ROCK INHIBITORS
    Publication number: 20170247357
    Abstract: The present invention relates to new kinase inhibitors, more specifically ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In particular, the present invention relates to new ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including Respiratory and Gastro-Intestinal diseases.
    Type: Application
    Filed: May 15, 2017
    Publication date: August 31, 2017
    Applicant: Redx Pharma PLC
    Inventors: Sandro Boland, Arnaud Bourin, Olivier Defert, Dirk Leysen
  • Pyridine derivatives as soft rock inhibitors
    Patent number: 9682963
    Abstract: The present invention relates to new kinase inhibitors of Formula (I) or a stereoisomer, tautomer, racemic, salt, hydrate, or solvate thereof, and more specifically to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including Respiratory and Gastro-Intestinal diseases.
    Type: Grant
    Filed: January 27, 2014
    Date of Patent: June 20, 2017
    Assignee: Redx Pharma PLC
    Inventors: Sandro Boland, Arnaud Bourin, Olivier Defert, Dirk Leysen
  • PYRIDINE DERIVATIVES AS SOFT ROCK INHIBITORS
    Publication number: 20150361072
    Abstract: The present invention relates to new kinase inhibitors of Formula (I) or a stereoisomer, tautomer, racemic, salt, hydrate, or solvate thereof, and more specifically to ROCK inhibitors, compositions, in particular pharmaceuticals, comprising such inhibitors, and to uses of such inhibitors in the treatment and prophylaxis of disease. In addition, the invention relates to methods of treatment and use of said compounds in the manufacture of a medicament for the application to a number of therapeutic indications including Respiratory and Gastro-Intestinal diseases.
    Type: Application
    Filed: January 27, 2014
    Publication date: December 17, 2015
    Applicant: AMAKEM NV
    Inventors: Sandro BOLAND, Arnaud BOURIN, Olivier DEFERT, Dirk LEYSEN